Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort
Duncan J Campbell, Fei Fei Gong, Michael Jelinek, Julian M Castro, Jennifer M Coller, Michele McGrady, Umberto Boffa, Louise Shiel, Bing H Wang, Danny Liew, Rory Wolfe, Simon Stewart, Alice J Owen, Henry Krum, Christopher M Reid, David L Prior
EUROPEAN JOURNAL OF HEART FAILURE | WILEY | Published : 2019
AIMS: We investigated which serum amino-terminal pro-B-type-natriuretic peptide (NT-proBNP) levels inform heart failure (HF) risk in a community-based population at increased cardiovascular disease (CVD) risk. METHODS AND RESULTS: Inclusion criteria were age ≥ 60 years with one or more of self-reported hypertension, diabetes, heart disease, abnormal heart rhythm, cerebrovascular disease, or renal impairment. Exclusion criteria were known HF, ejection fraction (EF) 76% and specificities of 47-69% for 5-year prediction of total HF in men and women in all three age groups. Sensitivities were ≥ 75% in most subgroups according to body mass index, estimated glomerular filtration rate, and the pre..View full abstract
Awarded by National Health and Medical Research Council of Australia
Awarded by National Heart Foundation of Australia
Awarded by Diabetes Australia Research Trust
This work was supported by Bupa Australia, with subsequent support from the National Health and Medical Research Council of Australia (GTN0559010, GTN1044619, GTN1092642, GTN0395508 to DJC, GTN1045862, GTN1136372 to CMR, GTN1041796 to SS, GTN0620241 to JM Coller, GNT0519456 to MM), the National Heart Foundation of Australia (G 07M 3198), the Diabetes Australia Research Trust (Y15G-CAMD), The University of Melbourne, St. Vincent's Hospital Melbourne, St. Vincent's Institute of Medical Research, and the Victorian Government's Operational Infrastructure Support Program.